Hello, Tombot family. I'm Tom Stevens, CEO and Co-Founder of Tombot. 

We’ve created Jennie, a fully interactive, robotic emotional support animal that will be the first affordable FDA medical device of its kind. 

My mother gave me my new purpose when she was diagnosed with Alzheimer's dementia. At that time, I had to take away her dog for safety reasons. I started looking around for substitutes for live animal companions but didn't find anything that she liked or would respond to, so I started wondering whether advanced robots might play a role.

That launched me on a multi-year research and education journey. Along the way, I learned that my mom's story isn't unique. 

Tens of millions of seniors around the world cannot safely or practically care for a live animal due to a health adversity. This means they miss out on the many mental health benefits and physical health benefits associated with the human-animal bond. 

We needed to make a change, so we launched Tombot in 2017 to help those people.

New Alternative To Dangerous Prescriptions 

Hello, Tombot family. I'm Tom Stevens, CEO and Co-Founder of Tombot. 

We’ve created Jennie, a fully interactive, robotic emotional support animal that will be the first affordable FDA medical device of its kind. 

My mother gave me my new purpose when she was diagnosed with Alzheimer's dementia. At that time, I had to take away her dog for safety reasons. I started looking around for substitutes for live animal companions but didn't find anything that she liked or would respond to, so I started wondering whether advanced robots might play a role.

That launched me on a multi-year research and education journey. Along the way, I learned that my mom's story isn't unique. 

Tens of millions of seniors around the world cannot safely or practically care for a live animal due to a health adversity. This means they miss out on the many mental health benefits and physical health benefits associated with the human-animal bond. 

We needed to make a change, so we launched Tombot in 2017 to help those people.

New Alternate To Dangerous Prescription 

Seniors with dementia suffer from behavioral and psychological symptoms, which include loneliness, depression, delirium, hallucinations, and violent anger. 

To manage those symptoms, doctors frequently prescribe psychotropic medications. Not only do psychotropics turn seniors into zombies, they carry many health risks.

Additionally, over 80% of seniors in skilled nursing facilities suffer from chronic pain. Historically the go-to medications have been opioids, and if you've been reading the paper at all for the last 10 or 15 years, you'll have heard about the epidemic surrounding those medications.

Doctors are urgently looking for alternatives to these medications.

Studies show that if a senior with dementia can form an emotional attachment to an object, that person enjoys a great deal of relief from the behavioral and psychological symptoms of dementia.

Research on robotic animals shows that they significantly outperform traditional emotional attachment objects and have the added benefit of reducing pain and the need for pain medications. 

Technology and Design of Jennie

We conducted multiple rounds of customer studies with hundreds of seniors with dementia, and what we learned is they have a very strong preference for realism. 

Realism in appearance, texture, and most importantly, behaviors. 

We went to Hollywood and teamed up with Jim Henson's Creature Shop to do all of our artistic design, and with their help we're building what we believe to be the world's most realistic robotic animal.

Jennie is designed to stimulate emotional attachment, at a price that most can afford. 

A little bit about the insides of Jennie: she's covered with sensors that allow her to feel where she's being touched, and she responds to voice commands. She can feel herself being moved and has other sensors to help her understand her environment. Resultantly, she exhibits behaviors that are consistent with live animals’.

Market and Leadership Team

The total addressable market is a very large one. 

There are about 16 million seniors with dementia or pre-dementia mild cognitive impairment in the US alone.

Despite 100% of our marketing on behalf of seniors with dementia, about 30% of our pre-order and waitlist customers have come in for other use indications.

We sell directly to the family members of the seniors with dementia, but we'll also distribute our product through: hospitals, adult daycare, assisted living and skilled nursing facilities. 

At $449, we will be the most feature-rich product in our class, while costing less than 1/10th of the price of our nearest competitor, PARO (which sells for over $6000).

Our leadership team has been together for 30 years and 25 years, respectively. We have the technical, operations, and business expertise to execute on our business plan. We are currently working on converting Jennie from a prototype into a manufacturable design.

We've raised about four million dollars to date, and we’re raising an additional five million to take us the rest of the way to our first customer shipments.

Invest in Tombot on StartEngine!

We hope you'll join us and bring robots to those desperately in need. 

We have close to 9,000 pre-orders from our wait list customers, including over 500 organizations such as:

• Hospitals
• Assisted living
• Skilled nursing facilities

You can make an impact today, and become an early investor in Tombot on our StartEngine crowdfunding raise page.

We look forward to continuing our journey with you.